Contraindication Signals Standard conservative practice excludes anyone with active gastrointestinal disease, type 1 diabetes, prior pancreatitis, medullary thyroid carcinoma history, or active cancer from any retatrutide protocol
Their broad gene-regulatory capacity continues to make them a compelling subject for researchers aiming to uncover the full spectrum of their therapeutic and cosmetic research applications
Injectable Dosage Injectable GHK-Cu is typically used for systemic effects or when topical delivery is insufficient: Standard range: 12 mg per injection, subcutaneous (SubQ) administration Common protocol: Daily or every-other-day injections, typically in 48 week cycles Concentration: Usually supplied as 10 mg/mL solution
Neuroprotection and Cognitive Function
We understand the unique needs of New Yorks residents, from busy professionals in Midtown to active families in Brooklyn and socialites enjoying weekends in SoHo and the Upper East Side